Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAlto Neuroscience Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.62 | -$0.43 | -$0.51 |
| Q2 2026 | 1 | -$0.58 | -$0.58 | -$0.58 |
| Q3 2026 | 1 | -$0.59 | -$0.59 | -$0.59 |
| Q4 2026 | 1 | -$0.65 | -$0.65 | -$0.65 |
| Q1 2027 | 1 | -$0.65 | -$0.65 | -$0.65 |
| Q2 2027 | 1 | -$0.72 | -$0.72 | -$0.72 |
| Q3 2027 | 1 | -$0.68 | -$0.68 | -$0.68 |
| Q4 2027 | 1 | -$0.77 | -$0.77 | -$0.77 |
Alto Neuroscience Inc. Earnings Date And Information
Alto Neuroscience Inc. last posted its earnings results on Wednesday, November 12th, 2025. The company reported $-0.52 earnings per share for the quarter, topping analysts' consensus estimates of $-0.66 by $0.14. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Alto Neuroscience Inc. has generated $-3 earnings per share over the last year ($-2.5 diluted earnings per share) and currently has a price-to-earnings ratio of -7.67. Alto Neuroscience Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Alto Neuroscience Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2025 | Q3 2025 | -$0.66 | -$0.52 | 0.14 | $0 | $0 |
| 08/13/2025 | Q2 2025 | -$0.57 | -$0.65 | -0.08 | N/A | $0 |
| 05/14/2025 | Q1 2025 | -$0.59 | -$0.56 | 0.03 | N/A | $0 |
| 03/20/2025 | Q4 2024 | -$0.65 | -$0.56 | 0.09 | N/A | $0 |
| 11/12/2024 | Q3 2024 | -$0.67 | -$0.62 | 0.05 | N/A | $0 |
| 08/13/2024 | Q2 2024 | -$0.71 | -$0.59 | 0.12 | N/A | $0 |
| 05/14/2024 | Q1 2024 | -$0.46 | -$0.50 | -0.04 | N/A | $0 |
| 03/21/2024 | Q4 2023 | -$1.67 | -$0.42 | 1.25 | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$0.34 | N/A | N/A | $0 |
| 06/28/2023 | Q2 2023 | N/A | -$0.32 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$0.27 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$0.30 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Alto Neuroscience Inc. Earnings: FAQ's
In the previous quarter, Alto Neuroscience Inc. (:ANRO) reported $-0.52 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.66 by $0.14.
The conference call for Alto Neuroscience Inc.'s latest earnings report can be listened to online.
The conference call transcript for Alto Neuroscience Inc.'s latest earnings report can be read online.
Alto Neuroscience Inc. (:ANRO) has a recorded net income of $-61,431,000.Alto Neuroscience Inc. has generated $-2.5 earnings per share over the last four quarters.
Alto Neuroscience Inc. (:ANRO) has a price-to-earnings ratio of -7.67 and price/earnings-to-growth ratio is -1.83.